Diacylglycerol specifically blocks spontaneous integration of membrane proteins and allows detection of a factor-assisted integration.
We recently found that the spontaneous integration of M13 procoat is blocked by diacylglycerol (DAG) (Nishiyama, K., Ikegami, A., Moser, M., Schiltz, E., Tokuda, H., and Muller, M. (2006) J. Biol. Chem. 281, 35667-35676). Here, we demonstrate that the spontaneous integration of Pf3 coat, another membrane protein that has been thought to be integrated spontaneously into liposomes, can be blocked by DAG at physiological concentrations. Moreover, the spontaneous integration of the membrane potential-independent version of Pf3 coat (3L-Pf3 coat), which is independent of YidC, was also blocked by DAG. To clarify the mechanism by which DAG blocks spontaneous integration, we examined lipid compounds similar to DAG and DAG derivatives. The blockage of spontaneous integration was specific to DAG, as fatty acids, monoacylglycerol, and phosphatidic acids were not effective for the blockage. When the acyl chains in DAG were shortened even to octanoyl residues, it still blocked spontaneous integration, whereas diheptanoylglycerol did not block it at all. Triacylglycerol was more effective than DAG. However, the lipid A-derivative-dependent integration of M13 procoat could not be reconstituted when triacylglycerol was included in the liposomes. On the other hand, when DAG was included in the liposomes, we found that the integration of 3L-Pf3 coat was strictly dependent on the lipid A-derived integration factor. We propose that the bulky structure of DAG rather than changes in membrane curvature is essential for the blockage of spontaneous integration. We also demonstrated that the blockage of spontaneous integration by DAG is also operative in native membrane vesicles.
Kawashima
Yosuke
Y
Institute of Molecular and Cellular Biosciences, University of Tokyo, Tokyo 113-0032, Japan.
Miyazaki
Emi
E
Müller
Matthias
M
Tokuda
Hajime
H
Nishiyama
Ken-ichi
K
D017104:Bacteriophage M13 / Q000378:metabolism*; D004075:Diglycerides / Q000378:metabolism / Q000494:pharmacology*; D004926:Escherichia coli / Q000378:metabolism*; D029968:Escherichia coli Proteins / Q000378:metabolism*; D008050:Lipid A / Q000378:metabolism / Q000494:pharmacology; D026901:Membrane Transport Proteins / Q000378:metabolism*; D021381:Protein Transport / Q000187:drug effects; D013329:Structure-Activity Relationship; D015678:Viral Structural Proteins / Q000378:metabolism*
D004075:Diglycerides; D029968:Escherichia coli Proteins; D008050:Lipid A; D026901:Membrane Transport Proteins; D015678:Viral Structural Proteins; C412443:YIDC protein, E coli